Vuse Gains Market Share Over Juul in Nielsen Report

Mar.10.2023
Vuse Gains Market Share Over Juul in Nielsen Report
Vuse's market share increased to 42.7%, surpassing Juul's 25.6% in Nielsen's convenience store report.

According to the latest Nielsen convenience store report, the market share of Vuse, an e-cigarette brand under Renault, has increased from 41.5% in the previous report to 42.7%, while Juul's market share has decreased from 26.4% to 25.6%.


Over the past 12 months, Vuse held a market share of 36.6% while Juul held a market share of 29.5%, according to data analysis conducted by Nielsen, which covers up to February 25th of this year.


NJOY, ranked third, maintained its position with 2.7% while Fontem Ventures' blu eCigs held steady at 1.4%.


On March 3rd, Altria announced that it had exchanged its 35% stake in Juul for exclusive intellectual property patents related to Juul's heated tobacco products. Following this, Altria acquired NJOY for $2.75 billion in cash.


According to the latest report, Juul's market share has decreased by 50.2%, to 25.7%, compared to a report from August 10, 2019.


In comparison, the sales growth of each brand from August 10th, 2019 to February of this year is as follows:


Renault's Vuse: Up 34%.


NJOY's stock has fallen by 8.7%.


blu eCigs experienced a 39.5% decrease in value.


Japan Tobacco's logic: Decreased by 4.9%.


In May 2019, Juul held a dominant 74.6% share of the electronic cigarette market in the United States. However, Nielsen's data did not include sales from e-cigarette stores, which could account for over 40% of all electronic cigarette product sales.


References:


The brand Vuse is continuing to increase its market share at the expense of its rival Juul.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
Product | OXBAR Lists GOSLIM Disposable Vape on Its Website, Featuring Embedded Leather and a Slim Display Window Design
OXBAR has updated its official website and listed a new disposable product, GOSLIM. The device is rated at 26,000 puffs, measures 40 × 22 × 110 mm, and weighs about 75 g, featuring an “embedded leather” exterior design. It supports two power modes—ECO and BOOST—and includes a digital display showing remaining battery percentage, remaining e-liquid level, and the active mode.
Jan.21 by 2FIRSTS.ai
IQOS UK unveils 2026 pop-up events plan, first stops set for London and three other cities
IQOS UK unveils 2026 pop-up events plan, first stops set for London and three other cities
IQOS’ UK website shows the company will roll out time-limited pop-up experience spaces across Britain in 2026 for adult consumers. The first confirmed locations are London, the West Midlands area near Birmingham, Manchester and Romford, offering product demonstrations, pop-up-only promotions and nicotine pouch sampling. Entry will be restricted to those aged 18 and over, with “Challenge 25” ID checks in place.
Feb.03 by 2FIRSTS.ai
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan to launch two new VELO nicotine pouch flavours in February
BAT Japan will roll out two new VELO nicotine pouch variants from Feb. 2, 2026: Smooth Peppermint Medium and Breezy Mango Intense. The products will be sold via the official glo & VELO online store, the glo Store Ginza and nationwide tobacco retail channels in Japan.
Jan.23 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
USITC Issues Final Ruling in 337-TA-1392 Investigation, Imposes Limited Exclusion Order and Cease and Desist Orders
USITC Issues Final Ruling in 337-TA-1392 Investigation, Imposes Limited Exclusion Order and Cease and Desist Orders
USITC issues final ruling on oil vaporizing devices, components violating tariff law, with limited exclusion order and cease-and-desist orders.
Jan.21 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24